Nexthera Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nexthera Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$7.49M	Buy	142,305 +55,206	+63%	+$3.17M	6.23%	6
2019 Q1	$4.61M	Sell	87,099 -134,563	-61%	-$6.61M	5.59%	7
2018 Q4	$9.1M	Sell	221,662 -327,569	-60%	-$12.3M	3.75%	10
2018 Q3	$20.9M	Buy	549,231 +145,139	+36%	+$6.43M	4%	9
2018 Q2	$18.3M	Buy	404,092 +88,945	+28%	+$4.05M	2.83%	9
2018 Q1	$15.2M	Buy	315,147 +3,631	+1%	+$203K	2.51%	12
2017 Q4	$12.3M	Buy	311,516 +41,441	+15%	+$1.55M	2.26%	13
2017 Q3	$8.39M	Sell	270,075 -70,025	-21%	-$1.97M	2.16%	16
2017 Q2	$9.3M	Buy	340,100 +135,600	+66%	+$4.03M	4.05%	10
2017 Q1	$7.54M	Buy	204,500 +144,500	+241%	+$3.64M	3.85%	11
2016 Q4	$867K	Buy	+60,000	New	+$1.05M	0.51%	33

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nexthera Capital's GBT Position: Q2 2019 in Review

Nexthera Capital increased its Global Blood Therapeutics, Inc. (GBT) stake by 63% in Q2 2019, buying an estimated $3.17M and bringing the position to 142,305 shares worth $7.49M. The position accounts for 6.23% of the portfolio, ranked #6.

Nexthera Capital first reported a position in GBT in Q4 2016 and has held it in 11 quarters since. The position peaked at $20.9M in Q3 2018. 223 funds tracked by Wall St. Rank hold GBT as of Q2 2019.

Nexthera Capital held 142,305 shares of Global Blood Therapeutics, Inc. worth $7.49M as of Q2 2019.
Nexthera Capital bought 55,206 Global Blood Therapeutics, Inc. shares in Q2 2019, an estimated $3.17M.
Global Blood Therapeutics, Inc. made up 6.23% of Nexthera Capital's portfolio in Q2 2019, its #6 holding.
Nexthera Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and has held it in 11 quarters since.
Nexthera Capital's Global Blood Therapeutics, Inc. position peaked at $20.9M in Q3 2018.
223 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.